Related Articles
The role of sphingolipid signalling in diabetes‑associated pathologies (Review)
Potential of a sphingosine 1‑phosphate receptor antagonist and sphingosine kinase inhibitors as targets for multiple myeloma treatment
Potential biomarkers Ang II/AT1R and S1P/S1PR1 predict the prognosis of hepatocellular carcinoma
Potential signaling pathway involved in sphingosine-1-phosphate-induced epithelial-mesenchymal transition in cancer (Review)
Sphingosine-1-phosphate inhibits the adipogenic differentiation of 3T3-L1 preadipocytes